-
Archives
- December 2017
- June 2017
- May 2017
- February 2017
- November 2016
- October 2016
- September 2016
- July 2016
- April 2016
- March 2016
- December 2015
- August 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- September 2014
- August 2014
- July 2014
- May 2014
- January 2014
- December 2013
- November 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
-
Meta
Monthly Archives: March 2013
With Prostate-Specific Antigen (PSA) Screening Questioned, Why Not Hurl Out the Next Unproven Prostate Tests?
The headline in the New York Times story this morning, “New Prostate Cancer Tests Could Reduce False Alarms,” by Andrew Pollack, had me scratching my head. Had I missed something in the story of advances in prostate cancer screening and … Continue reading
Posted in Prostate Cancer
Tagged false positives, Genomic Health, molecular markers, Myriad Genetics, PSA, screening, testing, treatment
Comments Off on With Prostate-Specific Antigen (PSA) Screening Questioned, Why Not Hurl Out the Next Unproven Prostate Tests?
Delay of Generics Hurts Consumer,Taxpayer Wallets, and Patient Health
To insure patent extensions of high-priced, blockbuster drugs, brand-name drug companies frequently pay generic drug manufacturers to stay out of the market. It makes cheaper, more affordable generic unavailable for years. The strategy is referred to as “Pay for … Continue reading
Posted in Drug costs
Tagged brand names, Community Catalyst, generic drugs, out-of-pocket costs, Pay-for-Delay, pharma, Supreme Court, Wells Wilkinson
Comments Off on Delay of Generics Hurts Consumer,Taxpayer Wallets, and Patient Health
Meeting Time, Ethical Issues in Psychiatry
I am heading to the annual meeting of the Association of Healthcare Journalists, have been occupied with paying work for a change, and cannot do the usual detailed post I do here. In the meantime, it’s worth flagging some recent health … Continue reading
Posted in mental health
Tagged antidepressants, antipsychotics, clinical trials, drug use, medical ethics, psychiatrists
1 Comment
Mental health medication: is it always A Bad Thing?
THIS is a guest post written by Martha Roberts, a journalist and mental health blogger in the UK, who writes the blog, Mentalhealthwise. Martha is on twitter @martharoberts01. Thank you, Martha. ###### ‘So when can you come off your medication, … Continue reading
Posted in mental health
Tagged antidepressants, bipolar, clinical trials, medication, pharma
6 Comments